200
Participants
Start Date
December 31, 2007
Primary Completion Date
March 31, 2008
Study Completion Date
March 31, 2008
Nitroglycerin
Individual pouch applicators containing 0.5 grams of Topical AmphiMatrix with Nitroglycerin. Each dose contains 4.5mg of Nitroglycerin. Each dose is intended for topical usage on both hands up to five minutes before an anticipated Raynaud's attack or up to 5 minutes after the beginning of an actual Raynaud's attack. Limited to four applications per day; minimum of two hours between applications.
Topical AmphiMatrix
Individual pouch applicators containing 0.5 grams of Topical AmphiMatrix. Each dose is intended for topical usage on both hands up to five minutes before an anticipated Raynaud's attack or up to 5 minutes after the beginning of an actual Raynaud's attack. Limited to four applications per day; minimum of two hours between applications.
SUNY Stony Brook, Stony Brook
The Center for Rheumatology, Albany
Georgetown University, Washington D.C.
Johns Hopkins University, Baltimore
Carolina Arthritis, Wilmington
Medical University of South Carolina, Charleston
University of Toledo, Toledo
Arthritis Education and Treatment Center, PLLC, Grand Rapids
Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
University of Chicago, Chicago
University of Texas at Houston, Houston
University of Colorado Health Sciences Center, Denver
Stanford University, Stanford
University of Connecticut, Farmington
Boston University, Boston
University of Medicine and Dentistry of New Jersey, New Brunswick
Lead Sponsor
MediQuest Therapeutics
INDUSTRY